The Advantages Of Loft Conversion6439496

kalapediasta
Tämä on arkistoitu versio sivusta sellaisena, kuin se oli 12. kesäkuuta 2014 kello 15.17 käyttäjän LinseymamuyigtvnWendeln (keskustelu | muokkaukset) muokkauksen jälkeen. Sivu saattaa erota merkittävästi tuoreimmasta versiosta.
(ero) ← Vanhempi versio | Nykyinen versio (ero) | Uudempi versio → (ero)
Siirry navigaatioon Siirry hakuun
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Iannis Adamopoulos, a UC Davis researcher who specializes in skeletal and immune-system diseases, may be selected as a possible Arthritis National Research Foundation (ANRF) Scholar and Sontag Foundation Fellow. Adamopoulos will get a grant of $75,000 to help his promising research on rheumatism. Among 13 ANRF scholars, he could be the only awardee to be identified by the Sontag Foundation. ANRF is just one of a small number of tax deductible charities specializing in Arthritis Research.


"We are happy to name Dr. Adamopoulos because Sontag Foundation Fellow for 2011," said philanthropist and Sontag Foundation President Rick Sontag. "His work may give you the next breakthrough to finally end the debilitating ailment that plagued my mother for 37 a number of ended her life." Adamopoulos, a helper professor of internal medicine, found out that an immune cytokine known as interleukin 23 (IL-23) is often a key regulator of joint inflammation and bone destruction. His finding that abnormal expression of IL-23 causes severe arthritis and bone reduction in mice was recently confirmed in human cells. Step 2 in his research is to discover the potential of IL-23 inhibitors as arthritis treatments. "Dr. Adamopoulos is shifting the main focus of arthritis research and bone health investigations toward immune-system cells not previously named significant," said Timothy Albertson, acting chair from the Department of Internal Medicine at UC Davis. "This change will probably use a profound relation to expanding therapeutic choices for those whose arthritis can't be managed with current treatments. It is admirable that this ANRF and Sontag Foundation possess the insight to identify his innovative work." Prior to joining UC Davis this season, Adamopoulos conducted drug discovery research at Schering-Plough Biopharma in Palo Alto, Calif. He holds a B.Sc. honors degree from the University of Surrey, an M.Phil. from University College London as well as a D.Phil. from your University of Oxford, Wolfson College, where he received a scholarship for research on inflammatory arthritis. Operating out of Long Beach, Calif., the ANRF provides research grants to outstanding, early-career scientists who're becoming leading researchers in rheumatic disease, autoimmunity and inflammation with all the objective of finding new control of debilitating, chronic diseases. The ANRF's highly competitive, NIH-level review process -- conducted by its Scientific Advisory Board -- helps to ensure that only top-tier applicants and projects are funded. Each year, the Sontag Foundation fully funds the grant associated with an ANRF-selected researcher who's studying rheumatism. To learn more about how you can make online donations visit curearthritis.org. The [http://shottergib.blogspot.com/2014/06/uc-davis-researcher-receives-grant-for.html is amongst the nation's leading medical schools, renowned for its research and primary-care programs. The college offers fully accredited master's degree programs in public places health insurance in informatics, as well as combined M.D.-Ph.D. program is training the next generation of physician-scientists to conduct high-impact research and translate discoveries into better clinical care. In addition to being a recognized leader in medical research, the institution is devoted to serving under served communities and advancing rural health.